science
plus
.abes.fr
|
explorer
À propos de :
Lapeyre-Mestre M.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Lapeyre-Mestre M.
Lapeyre-Mestre, Maryse
Lapeyre Mestre, Maryse
personal mailbox
maryse.lapeyre-mestre@univ-tlse3.fr
familyName
Lapeyre-Mestre
Lapeyre Mestre
Given name
M
M.
Maryse
is
relates
of
http://hub.abes.fr/bmj/periodical/ard/2008/volume_67/issue_5/B35044CA5E0355BDE053120B220AEE5A/authorship/4
http://hub.abes.fr/bmj/periodical/jnnp/1997/volume_63/issue_5/B35A3ACB742441C6E053120B220A637A/authorship/3
http://hub.abes.fr/edp/periodical/therapie/2013/volume_68/issue_4/th132154/authorship/1
http://hub.abes.fr/edp/periodical/therapie/2014/volume_69/issue_5/th142251/authorship/4
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150017/authorship/2
http://hub.abes.fr/edp/periodical/therapie/2009/volume_64/issue_6/th091809/authorship/2
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_2/th111929/authorship/2
http://hub.abes.fr/edp/periodical/therapie/2012/volume_67/issue_5/th122040/authorship/6
http://hub.abes.fr/edp/periodical/therapie/2013/volume_68/issue_3/th132095/authorship/4
http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_12/101093jacdkq351/authorship/7
http://hub.abes.fr/oup/periodical/bjaint/2006/volume_97/issue_2/101093bjaael168/authorship/7
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150010/authorship/1
http://hub.abes.fr/edp/periodical/therapie/2013/volume_68/issue_3/th132094/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2013/volume_68/issue_4/th132153/authorship/1
http://hub.abes.fr/edp/periodical/therapie/2014/volume_69/issue_6/th142242/authorship/2
http://hub.abes.fr/edp/periodical/therapie/2010/volume_65/issue_3/th101834/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_6/th111993/authorship/3
http://hub.abes.fr/edp/periodical/therapie/2012/volume_67/issue_5/th122057/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2008/volume_62/issue_6/th071604/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2009/volume_64/issue_5/th091781/authorship/6
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_1/th111939/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150006/authorship/1
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150012/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150013/authorship/5
http://hub.abes.fr/edp/periodical/therapie/2008/volume_63/issue_1/th081684/authorship/7
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_5/th111928/authorship/6
http://hub.abes.fr/springer/periodical/10286/1994/volume_4/issue_6/B955ACB5D495016EE053120B220A2AFC/authorship/2
http://hub.abes.fr/cairn/periodical/jgem/2018/issue_jgem182/D33CDC7CB53745D0E053120B220A6050/authorship/7
http://hub.abes.fr/edp/periodical/therapie/2014/volume_70/issue_3/therapie140015/authorship/3
http://hub.abes.fr/cairn/periodical/psyt/2013/issue_psyt191/D33B7AEBCD2A3B3FE053120B220AEA21/authorship/1
is
Contributor
of
Prescription drug abuse: which data in order to evaluate and prevent?
is
Author
of
http://hub.abes.fr/edp/periodical/therapie/2014/volume_70/issue_3/therapie140015/w
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs
http://hub.abes.fr/edp/periodical/therapie/2008/volume_63/issue_1/th081684/w
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_6/th111993/w
Pharmacoepidemiology Studies: what Levels of Evidence and how can They be Reached?
http://hub.abes.fr/edp/periodical/therapie/2014/volume_69/issue_6/th142242/w
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_5/th111928/w
Pharmacoepidemiology of Immune Thrombocytopenia: Protocols of FAITH and CARMEN Studies
Second Meeting of the French CEIP (Centres d'Évaluation et d'Information sur la Pharmacodépendance). Part I: How to Evaluate and Prevent the Abuse and Dependence on Hypnotic/Anxiolytic Drugs?
http://hub.abes.fr/edp/periodical/therapie/2010/volume_65/issue_3/th101834/w
http://hub.abes.fr/edp/periodical/therapie/2008/volume_62/issue_6/th071604/w
http://hub.abes.fr/edp/periodical/therapie/2009/volume_64/issue_5/th091781/w
http://hub.abes.fr/edp/periodical/therapie/2012/volume_67/issue_5/th122057/w
http://hub.abes.fr/edp/periodical/therapie/2013/volume_68/issue_4/th132153/w
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150006/w
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150012/w
Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital
Drugs and Cancer: an Analysis of the French Pharmacovigilance Database
http://hub.abes.fr/edp/periodical/therapie/2015/volume_70/issue_2/therapie150017/w
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_1/th111939/w
http://hub.abes.fr/edp/periodical/therapie/2011/volume_66/issue_2/th111929/w
Use of Drugs, Tobacco, Alcohol and Illicit Substances in a French Student Population
http://hub.abes.fr/edp/periodical/therapie/2013/volume_68/issue_3/th132094/w
Drug Abuse Monitoring: Which Pharmacoepidemiological Resources at the European Level?
Example of an Investigation of an “Emergent” Phenomenon in Addiction Vigilance: the Case of Methylphenidate
Death related to a recreational abuse of propofol at therapeutic dose range
Cost evaluation of Chronic Myeloid Leukemia (CML) management in Midi-Pyrenees region: economic impact of different Tyrosine Kinase Inhibitors
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
